Growth Metrics

Bruker (BRKRP) Cash & Current Investments (2016 - 2025)

Historic Cash & Current Investments for Bruker (BRKRP) over the last 17 years, with Q3 2025 value amounting to $321.4 million.

  • Bruker's Cash & Current Investments rose 7620.61% to $321.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $321.4 million, marking a year-over-year increase of 7620.61%. This contributed to the annual value of $209.5 million for FY2024, which is 5948.56% down from last year.
  • Latest data reveals that Bruker reported Cash & Current Investments of $321.4 million as of Q3 2025, which was up 7620.61% from $124.8 million recorded in Q2 2025.
  • In the past 5 years, Bruker's Cash & Current Investments ranged from a high of $1.2 billion in Q4 2021 and a low of $124.8 million during Q2 2025
  • In the last 5 years, Bruker's Cash & Current Investments had a median value of $574.8 million in 2023 and averaged $521.0 million.
  • As far as peak fluctuations go, Bruker's Cash & Current Investments crashed by 6489.21% in 2024, and later surged by 7620.61% in 2025.
  • Quarter analysis of 5 years shows Bruker's Cash & Current Investments stood at $1.2 billion in 2021, then plummeted by 43.12% to $664.5 million in 2022, then dropped by 22.18% to $517.1 million in 2023, then crashed by 59.49% to $209.5 million in 2024, then soared by 53.41% to $321.4 million in 2025.
  • Its last three reported values are $321.4 million in Q3 2025, $124.8 million for Q2 2025, and $215.7 million during Q1 2025.